|
|
 |
|
Five of the world's Top 10 Pharmaceutical Companies now license Argus Safety™.
Irvine, Calif. – January 8, 2008 – Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions for the pharmaceutical industry, announces that two more Top 10 pharmaceutical companies have chosen to license Argus Safety™ to manage their drug safety and risk management obligations. Furthermore, Relsys ended the month of December 2007 by signing seven additional new Argus clients, three of which are headquartered in Europe and four in the United States.
Argus Safety™ is already the world’s most widely used drug safety system, with more licensed users than any other application. Relsys now serves 50% of world’s Top 10 pharma and has the largest market share of Top 50 pharma companies. Numerous mid-sized and smaller companies, as well as dozens of hosted clients, also use Argus Safety™ to manage their regulatory compliance and drug safety needs.
Dave Bajaj, Relsys’ President and CEO, commented: “We are delighted to have been chosen by both of these companies as their drug safety software provider. Our global client growth this past year is unmatched in the drug safety and risk management space and underscores the confidence the industry has in our system. We look forward to continuing to serve the needs of the world-wide Argus family.”
John Loucks, Relsys’ Chief Customer Officer, commented: “The industry has clearly chosen the Argus Safety™ Suite as the premier drug safety and risk management solution. Relsys is committed to providing the most advanced and user-friendly system, as well as staying proactive on global regulatory compliance. The fact that we have taken a dominant position in the market is a clear sign to pharma companies of all sizes that Relsys is the best-of-breed solution to address their specific needs.” Sanket Agrawal, Relsys’ Chief Strategy Officer, added: “This selection clearly establishes the Argus Safety™ Suite as the blue-chip safety and risk management application suite for the world’s best pharmaceutical companies, meeting their complex global regulatory requirements as well as demanding technology and performance needs.”
Parties interested in learning more about the Argus Safety™ Suite, including the most advanced risk management capabilities in the industry, may visit the Relsys exhibit at the upcoming DIA Workshop on Contemporary Pharmacovigilance in January 2008 in Washington D.C. or can contact us at info@relsys.net.
About Relsys International
Relsys International provides the industry-leading Argus suite, a complete systems solution for Drug Safety, Pharmacovigilance and Risk Management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients’ corporate risk management strategies. Argus Safety™, the company’s flagship product, is the world’s widely-used drug safety and adverse event reporting software. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit www.relsys.net, or call +1 949-453-1715.
Back to News Headlines
|
|
